Lymphoma patients needed for trial
Axiom Veterinary Laboratories are looking for dogs that have been diagnosed with lymphoma in order to validate a test.
The test has been developed by Petscreen, to find acute phase proteins for monitoring remission in canine lymphoma patients.
Axiom will be performing a trial of Petscreen's work, to assess its ability to detect when a lymphoma patient is in and out of remission. If validated, vets old be provided with a method of identifying relapse earlier than palpation alone, which could potentially extend patient's lives.
To be involved in the trial, Axiom are looking for dogs that have cytologically or histologically confirmed lymphoma, diagnosed within two weeks of the first serum sample being taken. Preferably, they would not have received any treatment, including steroids.
The process will involve testing a serum sample taken from the patient at week zero, followed by monthly tests to monitor the patient's status, therefore, offering 100 patients six months of free remission monitoring.
If you would like a discussion, or have any patients you would like to put forward for the trial, please contact Emma Dewhurst of Axiom on 01626 355655 or via email.
Click here to find out more about Petscreen's work on the development so far.
The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.
